Cresset Asset Management, LLC Seagen Inc. Transaction History

Cresset Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $54,197 - $61,173	283 Added 0.92%	31,186 $6.62 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $5.8 Million - $6.37 Million	30,903 New	30,903 $5.95 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $418,635 - $552,475	-3,500 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$142.57 - $190.86 $141,144 - $188,951	990 Added 39.44%	3,500 $541,000
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $96,153 - $114,628	675 Added 36.78%	2,510 $426,000
Q2 2021 Aug 10, 2021	BUY	$135.08 - $161.1 $247,871 - $295,618	1,835 New	1,835 $290,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.